Brief: Theseus Pharmaceuticals Announces Preliminary Estimate Of Cash and Cash Equivalents Of About $211.8 Mln
05/01/2023 12:29
Jan 5 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS - PRELIMINARY, UNAUDITED ESTIMATE
OF
CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF DEC 31,
2022 OF ABOUT $211.8 MILLION
Source: (shorturl.at/cgJM0)
Further company coverage: THRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7